Methyl 3-methyl-1H-indole-7-carboxylate

Catalog No. :
ACKILD309
CAS No. :
1238214-62-4
Molecular Formula :
C11H11NO2
Molecular Weight :
189.21

IUPAC Name:methyl 3-methyl-1H-indole-7-carboxylate

Methyl 3-methyl-1H-indole-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$269.00Login to see priceIn stockInquiry
250mg95%$448.00Login to see priceIn stockInquiry
500mg95%$746.00Login to see priceIn stockInquiry
1g95%$1118.00Login to see priceIn stockInquiry
5g95%$3353.00Login to see priceIn stockInquiry
10g95%$5589.00Login to see priceIn stockInquiry
25g95%$11177.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-methyl-1H-indole-7-carboxylate
IUPAC Namemethyl 3-methyl-1H-indole-7-carboxylate
MDL No.MFCD20687896
Molecular FormulaC11H11NO2
Molecular Weight189.21
SMILESO=C(C1=CC=CC2=C1NC=C2C)OC
InChI KeyNGYBBCUWGHOUSB-UHFFFAOYSA-N
Synonym1238214-62-4 | METHYL 3-METHYL-1H-INDOLE-7-CARBOXYLATE | methyl3-methyl-1H-indole-7-carboxylate | 1h-indole-7-carboxylic acid,3-methyl-,methyl ester | starbld0006755 | SCHEMBL17798752 | SB14944 | E88273
CAS No.1238214-62-4
PubChem CID76846887

Synthetic Route by SureRoute

1. ACKILD309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACOBKP287 route compound structure diagram
    ACOBKP287882855-85-8 In Stock
  4. Then
  5. ACKILD309 route product structure diagram
    ACKILD3091238214-62-4 In Stock
Inquiry

2. ACKILD309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXGIU295 route compound structure diagram
    ACXGIU2951788043-93-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKILD309 route product structure diagram
    ACKILD3091238214-62-4 In Stock
Inquiry

Comments (0)